![Michael Cannon](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Michael Cannon
Direktor/Vorstandsmitglied bei MOLECULIN BIOTECH, INC.
Vermögen: - $ am 31.05.2024
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Walter Klemp | M | 64 | 9 Jahre | |
Donald Picker | M | 78 | 9 Jahre | |
Cheng Liu | M | 57 |
Eureka Therapeutics, Inc.
![]() Eureka Therapeutics, Inc. BiotechnologyHealth Technology Eureka Therapeutics, Inc. develops therapeutic monoclonal antibodies for cancer indication and treatment. It focuses on the discovery of fully-human antibody drugs for the treatment of cancer and utilizing its antibody drug discovery and engineering technologies, and advancing therapies for targeting previously inaccessible cancer antigens. The company was founded by Cheng Liu in 2006 and is headquartered in Emeryville, CA. | 18 Jahre |
Jacqueline Northcut | F | 62 |
Eureka Therapeutics, Inc.
![]() Eureka Therapeutics, Inc. BiotechnologyHealth Technology Eureka Therapeutics, Inc. develops therapeutic monoclonal antibodies for cancer indication and treatment. It focuses on the discovery of fully-human antibody drugs for the treatment of cancer and utilizing its antibody drug discovery and engineering technologies, and advancing therapies for targeting previously inaccessible cancer antigens. The company was founded by Cheng Liu in 2006 and is headquartered in Emeryville, CA. | 3 Jahre |
Peter P. Lee | M | - |
Osel, Inc.
![]() Osel, Inc. Pharmaceuticals: MajorHealth Technology Osel, Inc. develops and commercializes live bio therapeutic products that prevent abnormal conditions resulting from a disruption of the human micro biome. It offers Lactin-V and CBM588 products. The company was founded by Peter P. Lee in 2003 and is headquartered in Mountain View, CA. | 21 Jahre |
John Climaco | M | 55 | 7 Jahre | |
Chau Wai-Yan | M | - |
Eureka Therapeutics, Inc.
![]() Eureka Therapeutics, Inc. BiotechnologyHealth Technology Eureka Therapeutics, Inc. develops therapeutic monoclonal antibodies for cancer indication and treatment. It focuses on the discovery of fully-human antibody drugs for the treatment of cancer and utilizing its antibody drug discovery and engineering technologies, and advancing therapies for targeting previously inaccessible cancer antigens. The company was founded by Cheng Liu in 2006 and is headquartered in Emeryville, CA. | - |
Elizabeth Cermak | F | 66 | 4 Jahre | |
Robert George | M | 74 | 9 Jahre | |
Joy Yan | M | 44 | 2 Jahre | |
Han Zhong Li | M | 56 |
Eureka Therapeutics, Inc.
![]() Eureka Therapeutics, Inc. BiotechnologyHealth Technology Eureka Therapeutics, Inc. develops therapeutic monoclonal antibodies for cancer indication and treatment. It focuses on the discovery of fully-human antibody drugs for the treatment of cancer and utilizing its antibody drug discovery and engineering technologies, and advancing therapies for targeting previously inaccessible cancer antigens. The company was founded by Cheng Liu in 2006 and is headquartered in Emeryville, CA. | 5 Jahre |
Vivien Chan | M | - |
Eureka Therapeutics, Inc.
![]() Eureka Therapeutics, Inc. BiotechnologyHealth Technology Eureka Therapeutics, Inc. develops therapeutic monoclonal antibodies for cancer indication and treatment. It focuses on the discovery of fully-human antibody drugs for the treatment of cancer and utilizing its antibody drug discovery and engineering technologies, and advancing therapies for targeting previously inaccessible cancer antigens. The company was founded by Cheng Liu in 2006 and is headquartered in Emeryville, CA. | 10 Jahre |
William S. Solari | M | - |
Eureka Therapeutics, Inc.
![]() Eureka Therapeutics, Inc. BiotechnologyHealth Technology Eureka Therapeutics, Inc. develops therapeutic monoclonal antibodies for cancer indication and treatment. It focuses on the discovery of fully-human antibody drugs for the treatment of cancer and utilizing its antibody drug discovery and engineering technologies, and advancing therapies for targeting previously inaccessible cancer antigens. The company was founded by Cheng Liu in 2006 and is headquartered in Emeryville, CA. | - |
Sandy Chau | M | - |
Osel, Inc.
![]() Osel, Inc. Pharmaceuticals: MajorHealth Technology Osel, Inc. develops and commercializes live bio therapeutic products that prevent abnormal conditions resulting from a disruption of the human micro biome. It offers Lactin-V and CBM588 products. The company was founded by Peter P. Lee in 2003 and is headquartered in Mountain View, CA. | - |
Jonathan Foster | M | 60 | 8 Jahre | |
KT Moortgat | M | - |
Osel, Inc.
![]() Osel, Inc. Pharmaceuticals: MajorHealth Technology Osel, Inc. develops and commercializes live bio therapeutic products that prevent abnormal conditions resulting from a disruption of the human micro biome. It offers Lactin-V and CBM588 products. The company was founded by Peter P. Lee in 2003 and is headquartered in Mountain View, CA. | - |
John Paul Waymack | M | 71 | - | |
Sandra Silberman | M | 69 | 7 Jahre | |
Robert Lee | M | - |
Osel, Inc.
![]() Osel, Inc. Pharmaceuticals: MajorHealth Technology Osel, Inc. develops and commercializes live bio therapeutic products that prevent abnormal conditions resulting from a disruption of the human micro biome. It offers Lactin-V and CBM588 products. The company was founded by Peter P. Lee in 2003 and is headquartered in Mountain View, CA. | 31 Jahre |
Marvin Samson | M | 82 |
Eureka Therapeutics, Inc.
![]() Eureka Therapeutics, Inc. BiotechnologyHealth Technology Eureka Therapeutics, Inc. develops therapeutic monoclonal antibodies for cancer indication and treatment. It focuses on the discovery of fully-human antibody drugs for the treatment of cancer and utilizing its antibody drug discovery and engineering technologies, and advancing therapies for targeting previously inaccessible cancer antigens. The company was founded by Cheng Liu in 2006 and is headquartered in Emeryville, CA. | - |
Bo Feng | M | 53 |
Eureka Therapeutics, Inc.
![]() Eureka Therapeutics, Inc. BiotechnologyHealth Technology Eureka Therapeutics, Inc. develops therapeutic monoclonal antibodies for cancer indication and treatment. It focuses on the discovery of fully-human antibody drugs for the treatment of cancer and utilizing its antibody drug discovery and engineering technologies, and advancing therapies for targeting previously inaccessible cancer antigens. The company was founded by Cheng Liu in 2006 and is headquartered in Emeryville, CA. | - |
Chih Kai Cheng | M | - |
Eureka Therapeutics, Inc.
![]() Eureka Therapeutics, Inc. BiotechnologyHealth Technology Eureka Therapeutics, Inc. develops therapeutic monoclonal antibodies for cancer indication and treatment. It focuses on the discovery of fully-human antibody drugs for the treatment of cancer and utilizing its antibody drug discovery and engineering technologies, and advancing therapies for targeting previously inaccessible cancer antigens. The company was founded by Cheng Liu in 2006 and is headquartered in Emeryville, CA. | - |
Dennis McNamara | M | - | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
David Hale | M | 75 |
SICOR, Inc.
![]() SICOR, Inc. Pharmaceuticals: MajorHealth Technology Part of Teva Pharmaceutical Industries Ltd., SICOR, Inc. is a company that manufactures pharmaceuticals. The company is based in San Diego, CA. The company was founded by Harry E. Gruber, Jack W. Reich, Paul K. Laikind, Robert L. Engler. SICOR was acquired by Teva Pharmaceutical Industries Ltd. on January 22, 2004 for $3,297.10 million. | 10 Jahre |
John Sayward | M | 73 |
SICOR, Inc.
![]() SICOR, Inc. Pharmaceuticals: MajorHealth Technology Part of Teva Pharmaceutical Industries Ltd., SICOR, Inc. is a company that manufactures pharmaceuticals. The company is based in San Diego, CA. The company was founded by Harry E. Gruber, Jack W. Reich, Paul K. Laikind, Robert L. Engler. SICOR was acquired by Teva Pharmaceutical Industries Ltd. on January 22, 2004 for $3,297.10 million. | 5 Jahre |
David C. Dreyer | M | 67 |
SICOR, Inc.
![]() SICOR, Inc. Pharmaceuticals: MajorHealth Technology Part of Teva Pharmaceutical Industries Ltd., SICOR, Inc. is a company that manufactures pharmaceuticals. The company is based in San Diego, CA. The company was founded by Harry E. Gruber, Jack W. Reich, Paul K. Laikind, Robert L. Engler. SICOR was acquired by Teva Pharmaceutical Industries Ltd. on January 22, 2004 for $3,297.10 million. | 7 Jahre |
Paul Laikind | M | 68 |
SICOR, Inc.
![]() SICOR, Inc. Pharmaceuticals: MajorHealth Technology Part of Teva Pharmaceutical Industries Ltd., SICOR, Inc. is a company that manufactures pharmaceuticals. The company is based in San Diego, CA. The company was founded by Harry E. Gruber, Jack W. Reich, Paul K. Laikind, Robert L. Engler. SICOR was acquired by Teva Pharmaceutical Industries Ltd. on January 22, 2004 for $3,297.10 million. | 13 Jahre |
Martha L. Hough | F | 70 |
SICOR, Inc.
![]() SICOR, Inc. Pharmaceuticals: MajorHealth Technology Part of Teva Pharmaceutical Industries Ltd., SICOR, Inc. is a company that manufactures pharmaceuticals. The company is based in San Diego, CA. The company was founded by Harry E. Gruber, Jack W. Reich, Paul K. Laikind, Robert L. Engler. SICOR was acquired by Teva Pharmaceutical Industries Ltd. on January 22, 2004 for $3,297.10 million. | 11 Jahre |
John Roberts | M | 79 |
SICOR, Inc.
![]() SICOR, Inc. Pharmaceuticals: MajorHealth Technology Part of Teva Pharmaceutical Industries Ltd., SICOR, Inc. is a company that manufactures pharmaceuticals. The company is based in San Diego, CA. The company was founded by Harry E. Gruber, Jack W. Reich, Paul K. Laikind, Robert L. Engler. SICOR was acquired by Teva Pharmaceutical Industries Ltd. on January 22, 2004 for $3,297.10 million. | 2 Jahre |
Michael D. Casey | M | 78 |
SICOR, Inc.
![]() SICOR, Inc. Pharmaceuticals: MajorHealth Technology Part of Teva Pharmaceutical Industries Ltd., SICOR, Inc. is a company that manufactures pharmaceuticals. The company is based in San Diego, CA. The company was founded by Harry E. Gruber, Jack W. Reich, Paul K. Laikind, Robert L. Engler. SICOR was acquired by Teva Pharmaceutical Industries Ltd. on January 22, 2004 for $3,297.10 million. | 2 Jahre |
Louis Ploth | M | 70 | 1 Jahre | |
Barbara H. Deptula | F | 69 |
SICOR, Inc.
![]() SICOR, Inc. Pharmaceuticals: MajorHealth Technology Part of Teva Pharmaceutical Industries Ltd., SICOR, Inc. is a company that manufactures pharmaceuticals. The company is based in San Diego, CA. The company was founded by Harry E. Gruber, Jack W. Reich, Paul K. Laikind, Robert L. Engler. SICOR was acquired by Teva Pharmaceutical Industries Ltd. on January 22, 2004 for $3,297.10 million. | 1 Jahre |
Patricia L. Novak | M | - |
SICOR, Inc.
![]() SICOR, Inc. Pharmaceuticals: MajorHealth Technology Part of Teva Pharmaceutical Industries Ltd., SICOR, Inc. is a company that manufactures pharmaceuticals. The company is based in San Diego, CA. The company was founded by Harry E. Gruber, Jack W. Reich, Paul K. Laikind, Robert L. Engler. SICOR was acquired by Teva Pharmaceutical Industries Ltd. on January 22, 2004 for $3,297.10 million. | 6 Jahre |
Waldemar Priebe | M | - | - | |
Robert Shepard | M | 71 | - |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Vereinigte Staaten | 35 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Michael Cannon
- Persönliches Netzwerk